Europe PMCopen access
Efficacy and safety of 2-4 mg brexpiprazole in the management of schizophrenia: A systematic review and meta-analysis
Schizophrenia, Randomized controlled trials, Panss, Brexpiprazole, Cgi‐s
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 67574
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.